)
Visual21 Oct 2025
Hermès' growth by geographical region visualized
Jiangsu Hengrui Medicine (600276) investor relations material
Jiangsu Hengrui Medicine H1 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2025 earnings summary20 Aug, 2025
Executive summary
Revenue for the six months ended June 30, 2025, rose 15.9% year-over-year to RMB15,761.2 million, driven by innovative drug sales and licensing revenue.
Profit attributable to shareholders increased 29.7% year-over-year to RMB4,450.1 million, with net profit margin improving to 28.3%.
Innovative drugs and licensing revenue accounted for 60.7% of total revenue, with innovative drug sales at RMB7,569.8 million.
R&D investment remained high at RMB3,871.2 million, supporting a robust pipeline and multiple new product launches.
The company completed a successful H-share listing in Hong Kong, raising RMB10,300.4 million in net proceeds.
Financial highlights
Revenue increased to RMB15,761.2 million from RMB13,600.7 million year-over-year.
Profit for the period rose to RMB4,454.7 million from RMB3,428.1 million, with basic EPS up 29.6% to RMB0.70.
Net profit margin improved from 25.2% to 28.3% year-over-year.
Administrative, selling, and distribution expenses grew 10.9% to RMB5,799.3 million, but as a percentage of revenue, fell to 36.8%.
R&D expenses increased 6.3% to RMB3,227.9 million, representing 20.5% of revenue.
Outlook and guidance
Focus on quality and compliance in sales, with expansion into endocrinology, autoimmunity, and new distribution channels.
Continued investment in R&D platforms and global collaborations to accelerate innovative drug development and market entry.
Operational efficiency and digital transformation prioritized, alongside talent recruitment and leadership development.
Assess impact of generic drug procurement challenges.
Elaborate on global R&D footprint expansion plans.
What is the status of camrelizumab's US BLA?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Jiangsu Hengrui Medicine earnings date
Q3 202527 Oct, 2025
Next Jiangsu Hengrui Medicine earnings date
Q3 202527 Oct, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Jiangsu Hengrui Medicine Co., Ltd. is a China-based pharmaceutical company engaged in the research, development, production, and distribution of innovative medicines. The company focuses on therapeutic areas such as oncology, anesthesiology, cardiology, and endocrinology. It offers a diverse portfolio of pharmaceutical products, including chemical drugs, biologics, and injectables. The company is headquartered in Lianyungang, China, and its shares are listed on the Shanghai Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage